IDH1 and neoplasm: Intriguingly, in mouse xenografts, high doses of mutant IDH1 inhibitor caused tumour growth inhibition, methylation, and expression changes as well as astrocytic differentiation; however, even low doses were sufficient for an equivalent growth impairment despite no effect on the epigenetic or expression profile [39].